PL357108A1 - Związki heterobicykliczne zawierające azot jako inhibitory czynnika Xa - Google Patents

Związki heterobicykliczne zawierające azot jako inhibitory czynnika Xa

Info

Publication number
PL357108A1
PL357108A1 PL00357108A PL35710800A PL357108A1 PL 357108 A1 PL357108 A1 PL 357108A1 PL 00357108 A PL00357108 A PL 00357108A PL 35710800 A PL35710800 A PL 35710800A PL 357108 A1 PL357108 A1 PL 357108A1
Authority
PL
Poland
Prior art keywords
inhibitors
nitrogen containing
factor
heterobicycles
same
Prior art date
Application number
PL00357108A
Other languages
English (en)
Inventor
Irina C. Jacobson
Mimi L. Quan
Original Assignee
Bristol-Myers Squibb Pharma Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Pharma Company filed Critical Bristol-Myers Squibb Pharma Company
Publication of PL357108A1 publication Critical patent/PL357108A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL00357108A 1999-07-16 2000-07-12 Związki heterobicykliczne zawierające azot jako inhibitory czynnika Xa PL357108A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14434499P 1999-07-16 1999-07-16

Publications (1)

Publication Number Publication Date
PL357108A1 true PL357108A1 (pl) 2004-07-12

Family

ID=22508178

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00357108A PL357108A1 (pl) 1999-07-16 2000-07-12 Związki heterobicykliczne zawierające azot jako inhibitory czynnika Xa

Country Status (18)

Country Link
US (2) US6429205B1 (pl)
EP (1) EP1196412B1 (pl)
JP (1) JP2004507439A (pl)
KR (1) KR20030011268A (pl)
CN (1) CN1454211A (pl)
AT (1) ATE268766T1 (pl)
AU (1) AU2481501A (pl)
BR (1) BR0013200A (pl)
CA (1) CA2380727A1 (pl)
DE (1) DE60011430T2 (pl)
ES (1) ES2222257T3 (pl)
HK (1) HK1045502B (pl)
IL (1) IL147317A0 (pl)
MX (1) MXPA02000537A (pl)
NO (1) NO20020217L (pl)
PL (1) PL357108A1 (pl)
WO (1) WO2001005784A1 (pl)
ZA (1) ZA200200094B (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339099B1 (en) * 1997-06-20 2002-01-15 Dupont Pharmaceuticals Company Guanidine mimics as factor Xa inhibitors
JP2003502314A (ja) 1999-06-14 2003-01-21 イーライ・リリー・アンド・カンパニー 化合物
EP1255741A2 (en) 2000-02-01 2002-11-13 Cor Therapeutics, Inc. 2- 1H]-QUINOLONE AND 2- 1H]-QUINOXALONE INHIBITORS OF FACTOR Xa
EP1255743A1 (en) * 2000-02-01 2002-11-13 Millenium Pharmaceuticals, Inc. 3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE INHIBITORS OF FACTOR Xa
WO2001087834A1 (fr) * 2000-05-16 2001-11-22 Takeda Chemical Industries, Ltd. Antagoniste de l'hormone de concentration de la melanine
CN1439008A (zh) 2000-06-23 2003-08-27 布里斯托尔-迈尔斯斯奎布药品公司 作为因子xa抑制剂的1－(杂芳环基－苯基)－稠合吡唑衍生物
CA2409762A1 (en) 2000-06-23 2002-01-03 Donald J.P. Pinto Heteroaryl-phenyl substituted factor xa inhibitors
PL204263B1 (pl) 2001-09-21 2009-12-31 Bristol Myers Squibb Co Pochodna 1H-pirazolo[3,4-c]pirydyny i jej zastosowanie oraz kompozycja farmaceutyczna i jej zastosowanie
TWI331526B (en) 2001-09-21 2010-10-11 Bristol Myers Squibb Pharma Co Lactam-containing compounds and derivatives thereof as factor xa inhibitors
WO2003048081A2 (en) 2001-12-04 2003-06-12 Bristol-Myers Squibb Company Glycinamides as factor xa inhibitors
TW200302225A (en) 2001-12-04 2003-08-01 Bristol Myers Squibb Co Substituted amino methyl factor Xa inhibitors
BR0307178A (pt) 2002-01-22 2004-12-07 Du Pont Composto, composição e método para controle de pragas invertebradas
PT1490062E (pt) 2002-03-26 2008-01-30 Boehringer Ingelheim Pharma Miméticos de glucocorticóides, métodos para a sua preparação, composições farmacêuticas e suas utilizações
EP1505966A4 (en) 2002-05-10 2006-08-30 Bristol Myers Squibb Co 1,1-DISUBSTITUTED CYCLOALKYL DERIVATIVES AS FACTOR XA HEMMER
ATE403648T1 (de) * 2002-08-21 2008-08-15 Boehringer Ingelheim Pharma Substituierte dihydrochinoline als glucocorticoid-mmimetika,verfahren zu deren herstellung, pharmazeutische zubereitungen und deren verwendung
DK1569912T3 (en) 2002-12-03 2015-06-29 Pharmacyclics Inc 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors.
EP1479678A1 (en) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH Pyrazole-derivatives as factor xa inhibitors
US7429581B2 (en) 2002-12-23 2008-09-30 Sanofi-Aventis Deutschland Gmbh Pyrazole-derivatives as factor Xa inhibitors
CA2511321A1 (en) * 2002-12-23 2004-07-08 Aventis Pharma Deutschland Gmbh Pyrazole-derivatives as factor xa inhibitors
US7122557B2 (en) 2003-03-18 2006-10-17 Bristol-Myers Squibb Company Sulfonyl-amidino-containing and tetrahydropyrimidino-containing compounds as factor Xa inhibitors
US7129264B2 (en) * 2003-04-16 2006-10-31 Bristol-Myers Squibb Company Biarylmethyl indolines and indoles as antithromboembolic agents
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
US20050124664A1 (en) * 2003-10-30 2005-06-09 Eric Sartori Urea thiadiazole inhibitors of plasminogen activator inhibior-1
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
JP4912314B2 (ja) * 2004-10-26 2012-04-11 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 因子Ｘａ化合物
EP1836166B1 (en) 2004-12-27 2009-06-17 Boehringer Ingelheim Pharmaceuticals Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
GT200600042A (es) * 2005-02-10 2006-09-27 Aventis Pharma Inc Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a
DE102005038947A1 (de) 2005-05-18 2006-11-30 Grünenthal GmbH Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
BRPI0720131A2 (pt) 2006-12-06 2014-02-04 Boehringer Ingelheim Int Glicocorticoides miméticos, métodos para fazê-los, composições farmacêuticas e usos dos mesmos.
WO2008141081A1 (en) * 2007-05-10 2008-11-20 Amr Technology, Inc. Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
WO2009149139A1 (en) 2008-06-06 2009-12-10 Boehringer Ingelheim International Gmbh Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
BR112014030147B1 (pt) * 2012-06-22 2019-10-15 Sumitomo Chemical Company, Limited Compostos heterocíclicos fundidos, composição e método para controlar pestes
CN109475530B (zh) * 2016-05-23 2022-03-01 洛克菲勒大学 用于治疗自身免疫性疾病的氨酰基吲唑免疫调节剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001502655A (ja) 1995-12-21 2001-02-27 デュポン ファーマシューティカルズ カンパニー Ｘａ因子阻害薬であるイソオキサゾリン、イソチアゾリンおよびピラゾリン
IL130286A0 (en) * 1996-12-23 2000-06-01 Du Pont Pharm Co Nitrogen containing heteroaromatics as factor Xa inhibitors
ES2196396T3 (es) 1996-12-23 2003-12-16 Bristol Myers Squibb Pharma Co Compuestos heteroaromaticos de 5 miembros conteniendo oxigeno o azufre como inhibidores del factor xa.
ZA985247B (en) * 1997-06-19 1999-12-17 Du Pont Merck Pharma Guanidine mimics as factor Xa inhibitors.
WO1998057937A2 (en) 1997-06-19 1998-12-23 The Du Pont Merck Pharmaceutical Company Inhibitors of factor xa with a neutral p1 specificity group
IL136637A0 (en) 1997-12-22 2001-06-14 Du Pont Pharm Co Nitrogen containing heteroaromatics with ortho-substituted pi's as factor xa inhibitors

Also Published As

Publication number Publication date
KR20030011268A (ko) 2003-02-07
CN1454211A (zh) 2003-11-05
ATE268766T1 (de) 2004-06-15
DE60011430T2 (de) 2005-07-07
EP1196412B1 (en) 2004-06-09
EP1196412A1 (en) 2002-04-17
US6716841B2 (en) 2004-04-06
BR0013200A (pt) 2002-05-07
HK1045502A1 (en) 2002-11-29
IL147317A0 (en) 2002-08-14
ES2222257T3 (es) 2005-02-01
DE60011430D1 (de) 2004-07-15
NO20020217D0 (no) 2002-01-15
ZA200200094B (en) 2003-04-30
US20030096820A1 (en) 2003-05-22
US6429205B1 (en) 2002-08-06
WO2001005784A1 (en) 2001-01-25
HK1045502B (zh) 2004-12-10
JP2004507439A (ja) 2004-03-11
NO20020217L (no) 2002-03-15
AU2481501A (en) 2001-02-05
CA2380727A1 (en) 2001-01-25
MXPA02000537A (es) 2004-09-10

Similar Documents

Publication Publication Date Title
HK1045502A1 (en) Nitrogen containing heterobicycles as factor xa inhibitors.
WO2002000651A3 (en) Factor xa inhibitors
BR9908280A (pt) Inibidores de enzimas de fosfolipase
PL350042A1 (en) Serine protease inhibitors
GEP20074098B (en) Lactam-containing compounds and derivatives thereof as factor xa inhibitors
DE69816280D1 (de) Inhibitoren des impdh-enzyms
WO2000055124A3 (en) Novel compounds and compositions as protease inhibitors
NO990855L (no) Substituerte sykliske amin-metallprotease-inhibitorer
EP1862457A3 (en) Fluoropyrrolidines as dipeptidyl peptidase inhibitors
IL222773B (en) Biaryl compounds, pharmaceutical preparations containing them, use of such compounds for the manufacture of drugs and in vitro methods and devices using such compounds
WO2005099709A3 (en) Bicyclic heterocycles useful as serine protease inhibitors
NO983688L (no) Serin-protease-inhibitorer
WO2002080853A3 (en) Fused heterocyclic inhibitors of factor xa
WO2001044172A8 (en) Salicylamides as serine protease and factor xa inhibitors
WO2002020475A3 (en) Inhibitors of serine protease activity of matriptase or mtsp1
IL124883A0 (en) Amidino protease inhibitors and pharmaceutical compositions containing the same
WO2001070204A3 (de) Hochselektive inhibitoren des urokinase-plasminogenaktivators
WO2002002519A3 (en) THROMBIN OR FACTOR Xa INHIBITORS
WO2003015715A3 (en) Tetrahydroquinoline derivatives as antithrombotic agents
AU3864000A (en) Inhibitors of serine protease activity, methods and compositions for treatment of herpes viruses
AU8184301A (en) Inhibitors for the blood-clotting factor xa
AU3719100A (en) Inhibitors of serine protease activity, methods and compositions for treatment of viral infections
WO2002094197A3 (en) Bicyclic inhibitors of factor xa
MXPA04004450A (es) Nuevos compuestos y composiciones como inhibidores de catepsina s.
AUPP345098A0 (en) Novel anti-fibrinolytic agents

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)